# GelrinC

Type: Product

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/gelrinc
Canonical HTML page: https://getbiobrief.com/entity/gelrinc

## Recent coverage (2 stories)

### 5x Efficiency: Regentis Solvent-Free Patent Cements GelrinC’s Competitive Moat
2026-08-01 18:47:24 · Sentiment: Neutral · Impact: 5/10 · Sources: 3

Regentis’s Japanese patent allowance for a 5x more efficient, solvent-free manufacturing process strengthens its competitive position in the regenerative cartilage repair market. The milestone de-risks commercial scale-up as the company advances European launch and a pivotal U.S. trial.
Full story: https://getbiobrief.com/story/regentis-gelrinc-manufacturing-patent-bio

### Regentis Biomaterials Patents Solvent-Free Process, Boosting Yield by 400%
2026-03-17 15:29:38 · Sentiment: Very Bullish · Impact: 7/10 · Sources: 2

Regentis Biomaterials has patented a new solvent-free manufacturing process for its GelrinC hydrogel, achieving a 400% increase in production yield. This innovation streamlines the production of the cartilage-repair biomaterial while enhancing its environmental and regulatory profile.
Full story: https://getbiobrief.com/story/regentis-biomaterials-gelrinc-manufacturing-breakthrough

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.